Integrum AB
STO:INTEG B
Relative Value
The Relative Value of one INTEG B stock under the Base Case scenario is hidden SEK. Compared to the current market price of 9.76 SEK, Integrum AB is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
INTEG B Competitors Multiples
Integrum AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
I
|
Integrum AB
STO:INTEG B
|
254.1m SEK | 2.6 | -8.5 | -5.5 | -5.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.5B USD | 4.3 | 28.9 | 16.4 | 22.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.6B USD | 17.1 | 60.2 | 45.9 | 55.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.1B USD | 5.5 | 42.5 | 21.6 | 26.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.7B USD | 7 | 48.6 | 28.5 | 38.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
134.2B USD | 3.8 | 27.9 | 15.6 | 22.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.9B USD | 2.7 | 35.1 | 12.8 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR | 2 | 22.1 | 12.5 | 17.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.8B USD | 12.2 | 49.4 | 35.5 | 39.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 8.1 | 35 | 24.9 | 27.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37B USD | 6.8 | 24.7 | 17.4 | 19.4 |